G267-1095 Screening compound: 3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[2-(furan-2-yl)ethyl]propanamide

G267-1095 Screening compound: 3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[2-(furan-2-yl)ethyl]propanamide
G267-1095 Screening compound: 3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[2-(furan-2-yl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G267-1095
3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[2-(furan-2-yl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G267-1095

Molecular Formula

C22H28N6O3 (C22 H28 N6 O3)

Compound Name

3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[2-(furan-2-yl)ethyl]propanamide

IUPAC name

3-{35-dimethyl-1-[6-(morpholin-4-yl)pyridazin-3-yl]-1H-pyrazol-4-yl}-N-[2-(furan-2-yl)ethyl]propanamide

SMILES

Cc1c(CCC(NCCc2ccco2)=O)c(C)nn1-c(cc1)nnc1N1CCOCC1

InChI

InChI=1S/C22H28N6O3/c1-16-19(5-8-22(29)23-10-9-18-4-3-13-31-18)17(2)28(26-16)21-7-6-20(24-25-21)27-11-14-30-15-12-27/h3-4,6-7,13H,5,8-12,14-15H2,1-2H3,(H,23,29)

InChI Key

LXBXZSWBHQMYNL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14992452

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.506

Distribution Coefficient, logD

1.435

Water Solubility, LogSw

-1.87

Polar Surface Area

78.478

Acid Dissociation Constant (pKa)

14.38

Base Dissociation Constant (pKb)

6.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.50

G267-1095 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G267-1095 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G267-1095?
Check Price and Availability of G267-1095, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G267-1095 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G267-1095
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G267-1095
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G267-1095 available by request